Home / Assets / Cboe Global Markets (CBOE)
Stock

The best indicator for Cboe Global Markets (CBOE)

We backtested 20 indicators across daily, weekly and hourly charts on real Cboe Global Markets (CBOE) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.

Trend · Daily

EMA 20/50 Cross

On the daily chart, this is the strongest risk-adjusted edge we found for Cboe Global Markets (CBOE) over ~15.9 years — trailing buy-and-hold by 3.1% CAGR.

13.0%
CAGR
0.75
Sharpe
-29.9%
Max DD
50.0%
Win rate
4.4
Profit factor
-3.1%
vs Buy&Hold
Best by timeframe

The winner on each chart

Daily
EMA 20/50 Cross
-3.1% · Sharpe 0.75
Weekly
RSI Trend (>50)
-4.1% · Sharpe 0.7
Full results

Every indicator, ranked

Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.

#IndicatorTFCAGRSharpeMax DDWinTradesvs B&H
1EMA 20/50 Cross Daily13.0%0.75-29.9%50.0%34-3.1%
2RSI Trend (>50) Weekly12.3%0.7-37.2%56.8%37-4.1%
3WaveTrend (8/6/4) Daily10.1%0.67-36.1%76.8%56-6.1%
4Donchian Midline Weekly10.8%0.65-43.6%53.7%41-5.6%
5Donchian Breakout Weekly9.6%0.64-33.1%57.1%14-6.8%
6Stochastic Daily7.8%0.59-20.0%73.2%71-8.3%
7Williams %R Daily8.1%0.58-38.6%76.0%100-8.1%
8MACD Weekly8.3%0.55-38.3%53.1%32-8.1%
9Donchian Breakout Daily7.4%0.54-41.2%50.0%60-8.7%
10Rate of Change Weekly8.6%0.54-50.6%52.2%46-7.8%
11Heikin-Ashi Trend Weekly7.7%0.5-34.0%53.1%145-8.7%
12Bollinger Breakout Weekly6.7%0.49-40.9%63.2%19-9.7%
13Bollinger Breakout Daily5.4%0.48-30.2%44.3%79-10.8%
14EMA-10 Trend Weekly7.1%0.46-47.8%47.3%74-9.3%

= held up out-of-sample. Hypothetical, costs included. See methodology.

What this means

For Cboe Global Markets (CBOE), EMA 20/50 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.

More stock

Free · no spam

Get the weekly edge report

The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.